Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07532837) titled 'The Effect of Oral Probiotics on Allergic Rhinitis Symptoms and the Quality of Life' on April 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Glac Biotech Co., Ltd
Condition:
Allergic Rhinitis
Intervention:
Dietary Supplement: Lactobacillus rhamnosus F-1
Dietary Supplement: Lactobacillus rhamnosus F-1?Lactobacillus reuteri GL-104
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: February 26, 2024
Target Sample Size: 225
Countries o...